NEW 2,4-DIANILINOPYRIMIDINES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF ESSENTIALLY AS IKK INHIBITORS
申请人:BOUABOULA Monsif
公开号:US20100035907A1
公开(公告)日:2010-02-11
The disclosure relates to a compound of formula (I):
wherein R1, R2, R3, R4, R5, A and Y are as defined in the specification, to compositions containing them, to processes for preparing them, and to their use in the treatment or prevention of conditions capable of being modulated by the inhibition of the activity of protein kinases.
该披露涉及一种化合物的公式(I),其中R1、R2、R3、R4、R5、A和Y的定义如规范中所述,以及含有它们的组合物,制备它们的过程,以及它们在治疗或预防能够通过抑制蛋白激酶活性而调节的状况中的应用。